KRAS and lung carcinoma: Leveraging mouse models of Kras-mutant lung cancer, inducing cellular senescence by combined MEK and CDK4/6 inhibition provokes SASP-dependent and natural killer (NK) cell surveillance program and tumor cell death [167].